secwatch.observer — SEC 8-K summary
======================================

Issuer:     CITIUS ONCOLOGY, INC. (CTOR)
CIK:        0001851484
Form:       8-K
Filed at:   2024-05-21T23:59:59+00:00
Accession:  0001493152-24-020866
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TenX Keane Acquisition extends deadline to June 18, 2024 via $66,667 deposit from Citius Pharma
--------------------------------------------------------------------------------

- Citius Pharma deposited $66,667 on May 17, 2024 to extend business combination deadline from May 18 to June 18, 2024.
- The deposit is the second of up to seven monthly extensions allowed under the charter, originally expiring April 18, 2024.
- The extension is funded via an unsecured, non-interest-bearing promissory note repayable upon consummation of the business combination.
- Repayment of the note is conditioned on the trust account balance equaling or exceeding $2.0 million at closing of the merger with Citius Oncology.
- The merger agreement with Citius Pharmaceuticals and Citius Oncology was dated October 23, 2023, and remains pending.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851484/000149315224020866/0001493152-24-020866-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851484/000149315224020866/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-020866

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer